Structural and biomechanical responses of osseous healing: a novel murine nonunion model
- First Online:
- Cite this article as:
- Chaubey, A., Grawe, B., Meganck, J.A. et al. J Orthopaed Traumatol (2013) 14: 247. doi:10.1007/s10195-013-0269-4
- 646 Views
Understanding the biological mechanisms of why certain fractures are at risk for delayed healing or nonunion requires translational animal models that take advantage of transgenic and other genetic manipulation technologies. Reliable murine nonunion models can be an important tool to understand the biology of nonunion. In this study, we report the results of a recently established model for creating critical defects that lead to atrophic nonunions based on a unique fracture fixation technique.
Materials and methods
Subcritical (0.6 mm long) and critical (1.6 mm long) defects were created in femurs of 10-week-old double transgenic (Col1/Col2) mice and stabilized using a custom-designed plate and four screws. Four groups were used: normal, sham, subcritical, and critical. Histology (n = 3 for each group) was analyzed at 2 and 5 weeks, and micro-computed tomography (μCT) and torsional biomechanics (n = 12 for each group) were analyzed at 5 weeks.
Subcritical defects showed healing at 2 weeks and were completely healed by 5 weeks, with biomechanical properties not significantly different from normal controls. However, critical defects showed no healing by histology or μCT. These nonunion fractures also displayed no torsional stiffness or strength in 10 of 12 cases.
Our murine fracture model creates reproducible and reliable nonunions and can serve as an ideal platform for studying molecular pathways to contrast healing versus nonhealing events and for evaluating innovative therapeutic approaches to promote healing of a challenging osseous injury.
Fracture healing is an efficient process that leads to the formation of new bone. However, about 10 % of the estimated 5.6 million fractures that occur in the USA annually lead to nonunions [1, 2]. Expenses related to fractures and associated problems are predicted to increase to over US $74 billion by 2015 . Thus, the socioeconomic impact of these injuries cannot be underestimated.
Previous studies have established rodent models for investigating delayed osseous healing [4–6]. However, these models can be technically demanding  and not reproducibly manifest clinically relevant scenarios. Murine models have become particularly attractive with the advent of transgenic animals and genome manipulation techniques, and the availability of gene-targeted antibodies [7, 8]. Bone healing occurs in response to injury and is orchestrated by a series of clearly defined events. Although we do understand the basic mechanisms of bone formation, questions still remain as to why an injury, such as a nonunion, does not display a normal healing cascade.
Our group has been studying spatial and temporal Col1/Col2 expression patterns during healing of soft and hard tissue injuries. We bred a unique double transgenic (DT) mouse, pOBCol3.6GFPtpz (Col1) and pCol2-ECFP (Col2), to study tendon midsubstance and insertion-site injuries . This mouse also offers the potential for tracking molecular events in nonunion bone fractures, as Col1 and Col2 are critically involved in bone healing.
The objective of this study is to determine the efficacy of our model in creating a sustained fracture nonunion that could be utilized in future studies to investigate the biological events governing bone healing. In this study, we utilized a unique plate and screw fixation developed by Goldstein and colleagues at the University of Michigan.
Materials and methods
Histology and biomechanics were examined in 36 10-week-old male DT mice (72 limbs), containing the transgenes pOBCol3.6GFPtpz and pCol2-ECFP. Four treatment groups were tested in this study: (1) nonoperated control (normal), (2) surgical sham consisting of internal fixation without fracture (sham), (3) subcritical fracture (0.6 mm long) consisting of a surgically induced transverse fracture with internal fixation (subcritical), and (4) critical fracture (1.6 mm long; exceeding the local bone diameter) with internal fixation (critical). Bilateral surgeries were performed, and the groups were randomized among limbs. Histology of the defects (n = 3 for each group) was analyzed at 2 and 5 weeks postsurgery, and biomechanics (n = 12 for each group) at 5 weeks postsurgery.
All animal protocols were approved by the University of Cincinnati Institutional Animal Care and Use Committee.
Femurs were excised, trimmed of skin, and fixed in 10 % neutral buffered formalin (HT501320.9; Sigma) at 4 °C before shipment to the Rowe laboratory for histological imaging. The fixator device was removed after the femur was radiographed at 24 kV for 8 s with a digital X-ray (LX 60; Faxitron, USA). Subsequently, each femur was soaked overnight in 30 % sucrose/phosphate-buffered saline (PBS) solution, positioned in Neg-50 frozen-section medium (Richard-Allan Scientific, MI), frozen over chilled methylbutane, and kept at −20 °C. Longitudinal full-length 5-μm cryosections were taken either in line with or in cross-section to the screw holes (CM3050S cryostat; Leica, Germany) using a steel blade (cat# 3051835; Fisher Scientific, MA) and nonautofluorescent adhesive film (Section Lab, Co., Ltd., Toyota-gun, Hiroshima, Japan). Three sections were taken at three different depths, and each section was transferred to a glass slide, soaked for 10 min in PBS, stained in 30 mg/mL calcein blue solution (#M1255-1G; Sigma) for 30 min, and cover-slipped with 50 % glycerin in PBS prior to microscopy for the endogenous fluorescent signals.
After imaging of the endogenous signals, the cover-slip was removed and the slide was processed for additional stains. Osteoclasts were identified using fluorescent ELF-97 phosphatase substrate (E6589; Invitrogen), to detect tartrate-resistant acid phosphatase (TRAP) activity. Next, the slide was stained for alkaline phosphatase (AP) activity. After washing in PBS, the slide was re-cover-slipped for imaging using 50 % glycerol containing 10 μg/mL Hoechst 33342 (#H-3570; Molecular Probes). Hematoxylin only or hematoxylin and eosin (H&E) staining was performed on the same slides once the fluorescent staining and imaging were completed. After the cover-slip was removed, the slides were first stained in Myers modified hematoxylin solution (#S216-16 oz; Poly Scientific R&D Corp) for 1 min and then washed with tap water. Then, slides were soaked in bluing solution (#6769001; Shandon) for 2 min and washed with tap water. Slides were then cover-slipped again for imaging.
Fluorescent expression within the femoral sections was examined at 2 and 5 weeks using a Zeiss Mirax Midi scanning fluorescent microscope (Carl Zeiss, Thornwood, NY) and imaged with a high-resolution monochrome digital camera (Zeiss AxioCamHRm). A differential interference contrast (DIC) image was acquired at the same time as the endogenous fluorescence imaging. After detecting bone mineralization with three filters [4′,6-diamidino-2-phenylindole (DAPI), Chroma, #49000ET; Col3.6 blue with cyan fluorescent protein (CFP) (blue), #49001ET; Col3.6 green with yellow fluorescent protein (YFP), 49003 ET], each slide was removed and stained with ELF-97 and reimaged with a yellow filter optimized for tetracycline (Custom HQ409sp, 425dcxr, HQ555/30, set lot C-104285; Chroma Technology). Sections were then stained for: (a) AP activity [fast red substrate with tetramethylrhodamine isothiocyanate (TRITC) filter; Chroma 49005 ET], and (b) hematoxylin imaging (Zeiss AxioCamMRc 5 color camera). The Mirax software created an image stack for each filter setting that could be merged and exported.
Micro-computed tomography (μCT) imaging and biomechanical analysis
At 5 weeks postoperatively, the femora were excised, trimmed of skin and muscle, and frozen at −80 °C before shipment overnight on dry ice to the Awad laboratory for micro-CT imaging and biomechanical testing. On the day of mechanical testing, each femur was thawed and scanned by micro-CT (VivaCT 40; Scanco Medical, Bassersdorf, Switzerland) at 70 kVp and 145 μA with 300 ms integration time.
Specimens were then hydrated for 1 h in PBS. Each femur was potted in poly(methyl methacrylate) (PMMA) bone cement (DePuyOrthopaedics, Inc., IN) in sections of square aluminum tubing in a custom jig to ensure axial alignment and constant gage length. The bone cement was allowed to set for 2 h prior to rehydration in PBS at room temperature for 1–2 h. Plated specimens were centered in the gage length based on the center of the fixation plate. Nonplated specimens were centered in the gage length based on anatomical landmarks (lateral ridge on the proximal half) for consistency. Prior to testing, the titanium plates were cut perpendicularly through the center using a hand Dremel and a stainless steel, diamond coated disc (Part # 011960U0, Brasseler USA Dental Instrumentation, GA). A #11 scalpel blade was inserted in the space between the bone and plate to protect the femur from the Dremel blade during cutting. Specimens were tested in torsion using an EnduraTec TestBench system (200 N-mm torque cell; Bose Corporation, MN) at 1°/s until failure. Testing was stopped if specimens showed no torsional resistance by 30–40° of rotation.
Biomechanical properties from the normal, sham, subcritical, and critical defects were compared using two-way analysis of variance (ANOVA). Tukey’s honestly significant difference (HSD) post hoc comparisons were made in the event of statistical significance (p < 0.05). All data were analyzed using SPSS 13.0 (Chicago, IL).
Figures in this section show representative images for each scenario, for each treatment and time point.
Calcein blue staining revealed Col3.6GFP-positive cells within the metaphyseal bone in normal controls (Suppl. Fig. 1b). Modest GFP signal suggested little endosteal activity in these nearly skeletally mature animals. Osteoclasts (stained by ELF-97 for TRAP) were limited to the metaphysis. Col2A1-positive, blue chondrocytes were scattered but restricted to the articular cartilage and growth plate (Suppl. Fig. 1c). Most bone surfaces showed weak AP staining with DAPI-positive osteocytes within the cortical bone and marrow space (Suppl. Fig. 1d).
At 2 weeks, the cortical bone in the sham-operated control group showed a strong periosteal response around the screw holes (Suppl. Fig. 2a, b). New periosteal bone formation as well as GFP+ bone surface cells (Suppl. Fig. 2c, d) could be seen along the bone surface, especially near the proximal screw hole. Remodeling activity had diminished by 5 weeks, indicating the hardware was well tolerated (Suppl. Fig. 3a, b). Bone cells expressing endogenous Col1 (GFP) were evident, especially around the screw holes (Suppl. Fig. 3b, c). AP staining was visible along the bone and in the growth plates (Suppl. Fig. 3d).
Micro-CT and biomechanical analyses
Biomechanical analysis was performed on 42 of the 48 samples (n = 11 each for normal and sham; n = 10 each for subcritical and critical). Four samples were lost during mechanical testing (n = 2 each for subcritical and critical), and two others were deemed as outliers as their values were more than 2.5 standard deviations (SDs) away from the mean (n = 1 each for normal and sham).
Biomechanical properties (mean ± SD) for subcritical and critical defects
Rotation at yield (rad/mm)
Rotation at failure (rad/mm)
Energy to failure (N-rad/mm)
0.017 ± 0.002
0.025 ± 0.003
0.413 ± 0.04
0.02 ± 0.003
0.027 ± 0.004
0.492 ± 0.17
0.016 ± 0.004
0.021 ± 0.004
0.223 ± 0.14
0.002 ± 0.005*
0.003 ± 0.01*
0.022 ± 0.07*
Both subcritical and critical defects negatively affected the maximum torque. Values for the critical group (1.6 ± 3.7 N-mm) and subcritical group (19.59 ± 11.44 N-mm) were significantly less than the mean maximum torque for the normal group (31.777 ± 3.47 N-mm) (p < 0.001 and p < 0.05, respectively; Fig. 7). The maximum torque for the sham group (37.481 ± 10.6 N-mm) was not significantly different from the mean value for the normal group (Fig. 7).
Critical defects also adversely affected failure properties in torsion. The failure values for the critical group were significantly less than the corresponding failure values for the normal group (p < 0.05 for rotation at failure and energy to failure, Table 1). Sham and subcritical groups were not significantly different from the mean values for the normal group (p > 0.05; Table 1).
In this study, we created a reproducible bone defect healing model to monitor early biological and later biomechanical changes in osseous healing. In our model, subcritical defects were healed by week 5 and were functionally similar to normal controls. By contrast, critical defects did not show any healing by week 5. Histologically, the presence of the “capped” and remodeled fracture ends explains the biomechanical findings. This capping would likely preclude any further boney bridging or osseous remodeling across the fracture site . Biomechanically, critical defects at 5 weeks showed no functional strength. Furthermore, the critical defect group did not demonstrate any progression of healing during serial x-ray examination; in fact, resorption of bone at the ends of the fracture was observed. These findings are consistent with an atrophic nonunion pattern.
The importance of osteo- and chondrogenic cells from periosteum in callus formation following long-bone fractures has been previously demonstrated . Periosteum can drive direct expansion of the original cortical bone without a fibrocartilaginous intermediate stage. We believe this was the mechanism of healing in our model, as we did not see a fibrocartilage core in histology. Endochondral ossification cannot be entirely ruled out, as we did not examine healing earlier than 2 weeks postfracture.
Importantly, periosteal repair is least successful when the fracture ends form a “cap” by migrating inwards. Fibrosis then fills the defect space, and the consequence of this “pseudoarthrosis” is a lack of a periosteal response and new bone formation, the classic “atrophic nonunion.” This phenomenon was seen in critical defects, which displayed “capped” ends.
Our model differs from those of other groups who have reported nonunion models [7, 10, 12]. One advantage of our plate model is the ability to create a reproducible gap that leads to union (0.6 mm) or nonunion (1.6 mm). This can allow for investigation of a variety of treatment strategies ranging from grafts to tissue engineering solutions. It also creates a reproducible volume of repair blastema, enabling molecular and histologic assays. Furthermore, the DT mice offer an ideal model to further study osseous repair, and the response of collagen 1 and 2.
This research is not without limitations. (1) Biomechanical testing was done only at week 5. Since there is no universal definition of nonunions, it has been suggested that they should not be defined arbitrarily in terms of duration, but rather as the ending of the intramembranous healing response . Since the critical defects had “capped” fracture ends, displayed characteristics of true atrophic nonunion, and did not possess any measurable strength even at 5 weeks, we suggest that it is highly unlikely that the critical defects would heal at any later time point, thereby becoming established nonunions. (2) It can be argued that the transgenic manipulation of the mice used in this study could have affected the healing properties. While in most cases a reporter does not have an impact on development and healing, this is still an open question. Since these changes are not readily predictable and highly variable, it will take proper controls in the future to understand their impact, if any, on healing.
Unique in this study is the presence of two fracture models: a subcritical defect that achieves “functional” repair, and a critical defect that does not. We hope to understand cellular and molecular mechanisms that permit repair in one case and then formulate approaches to healing critical defects that lead instead to nonunions. Our long-term goal remains to discover clinically relevant alternatives to treat fracture nonunions by completing fundamental and translational preclinical studies that meet biomechanical and biological design criteria.
This study was funded by NIH grants AR56943-02 and AR46574-10 and by an internal University Orthopaedic Research and Education Foundation (UOREF) grant. The authors would like to thank Cynthia Gooch and Charles Roehm for excellent technical assistance.
Conflict of interest
Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.